Invasive Airway

Mostafa Mohammadi; Alireza Khafaee Pour Khamseh; Hesam Aldin  Varpaei

doi:10.5812/aapm.115868

https://doi.org/10.5812/aapm.115868

Invasive Airway "Intubation" in COVID-19 Patients; Statistics, Causes, and Recommendations: A Review Article

authors:

Mostafa Mohammadi ¹ , Alireza Khafaee Pour Khamseh ² , Hesam Aldin Varpaei ^{3
, 2
, *}

1 Department of Anesthesiology and Critical Care, Department of Spiritual Health, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

2 Islamic Azad University Tehran Medical Sciences, Tehran, Iran

3 Department of Nursing, Michigan State University, USA

Anesthesiology and Pain Medicine: Vol.11, issue 3; e115868

published online: July 9, 2021

article type: Review Article

received: May 18, 2021

revised: June 16, 2021

accepted: June 16, 2021

how to cite: Mohammadi M, Khafaee Pour Khamseh A, Varpaei H A . Invasive Airway "Intubation" in COVID-19 Patients; Statistics, Causes, and Recommendations: A Review Article. Anesth Pain Med. 2021;11(3):e115868. https://doi.org/10.5812/aapm.115868.

Abstract

Context:

Severe coronavirus disease 2019 (COVID-19) can induce acute respiratory distress, which is characterized by tachypnea, hypoxia, and dyspnea. Intubation and mechanical ventilation are strategic treatments for COVID-19 distress or hypoxia.

Methods:

We searched PubMed, Embase, and Scopus databases to identify relevant randomized control trials, observational studies, and case series published from April 1, 2021.

Results:

24 studies were included in this review. Studies had been conducted in the USA, China, Spain, South Korea, Italy, Iran, and Brazil. Most patients had been intubated in the intensive care unit. Rapid sequence induction had been mostly used for intubation. ROX index can be utilized as the predictor of the necessity of intubation in COVID-19 patients. According to the studies, the rate of intubation was 5 to 88%. It was revealed that 1.4 - 44.5% of patients might be extubated. Yet obesity and age (elderly) are the only risk factors of delayed or difficult extubation.

Conclusions:

Acute respiratory distress in COVID-19 patients could require endotracheal intubation and mechanical ventilation. Severe respiratory distress, loss of consciousness, and hypoxia had been the most important reasons for intubation. Also, increased levels of C-reactive protein (CRP), ferritin, d-dimer, and lipase in combination with hypoxia are correlated with intubation. Old age, diabetes mellitus, respiratory rate, increased level of CRP, bicarbonate level, and oxygen saturation are the most valuable predictors of the need for mechanical ventilation. ICU admission mortality following intubation was found to be 15 to 36%. Awake-prone positioning in comparison with high-flow nasal oxygen therapy did not reduce the risk of intubation and mechanical ventilation. There was no association between intubation timing and mortality of the infected patients. Noninvasive ventilation may have survival benefits.

Keywords

Intubation SARS-CoV-2 Critical Care Acute Respiratory Distress Syndrome Airway Extubation, Hypoxia Airway Management.

1. Context

Tracheal intubation is a clinical procedure to place a flexible tube into the trachea with the aim of keeping a safe airway and establishing ventilation. Some circumstances may require intubation, such as loss of consciousness, major surgeries, decreased oxygen saturation (hypoxemia), airway obstruction (laryngospasm), or respiratory diseases, such as acute respiratory distress syndrome (1, 2). Because intubation is an invasive and uncomfortable procedure, it is often performed under general anesthesia and using a neuromuscular-blocking medication.

During the coronavirus disease 2019 (COVID-19) pandemic, because infected patients develop acute respiratory distress and respiratory failure, putting invasive airways can prevent the disease progression (1-3). Almost 14 - 30% of hospitalized COVID-19 patients develop a respiratory failure at different degrees (moderate to severe) and may need intensive care (4-6) so that less than 5% of COVID-19 patients required intubation and invasive ventilation at some stages of respiratory failure (7). The need for intubation and mechanical ventilation in cases who are critically ill is vary ranging from 30 to 100% (8).

Currently, different statistics are provided on the intubation rate of COVID-19 patients in intensive care units (ICUs). On March 4, 2020, 3.2% of infected cases in China required intubation (7). Also, in a study conducted in New York, 12.2 to 33.1% of COVID-19 patients needed intubation (4, 9). The duration of intubation is different for each patient. Wali et al. examined the course of five COVID-19 patients who needed invasive oxygen therapy (10). It was found that most patients were intubated in the first 2 days of admission. The duration of ventilation with an endotracheal tube was between 4 and 30 days. Intubation can be due to various reasons, like decreased oxygen saturation, respiratory distress, and acute respiratory distress syndrome (11). In this situation, intubation at the right time is very important, and delayed intubation can cause patients' death (12). Xiao Lu showed that mortality in intubated patients with COVID-19 is higher than in patients who were not intubated (13). Most intubations are performed in the ICUs. According to recent studies, more than 10% of COVID-19 patients in northern Italy who suffered from hypoxia were intubated in the ICU (14). It is reported that old age, diabetes mellitus, respiratory rate, increased level of C-reactive protein, bicarbonate level, and oxygen saturation are the most valuable predictors of the need for mechanical ventilation (15). One of the distinguishing characteristics of hypoxia in COVID-19 patients is “the happy hypoxic”, which means that the patient is mentally alert and there is no significant respiratory distress, but low blood oxygen saturation can be developed (16). These patients are at high risk of rapid status deterioration without any signal; thus, they should be under close monitoring, and preemptive action should be taken into account (17).

The timing of intubation, as well as the making decision to perform endotracheal intubation, may be unique for COVID-19 patients case by case (18). The threshold for intubation may be lower in COVID-19 because the use of high-flow nasal oxygen (2) or supposedly noninvasive ventilation can increase the risk of disease transmission to healthcare providers. Therefore, early, controlled intubation may also increase the safety zone of intubation through enough preparation time for this high-risk procedure. The application of airborne precautions is highly recommended throughout … (19, 20). The most serious clinical characteristics of respiratory insufficiency in patients with COVID-19 are hypoxemia and increased breathing (tachypnea). To avoid oxygen toxicity in oxygen therapy, patients should be monitored closely in the ICUs (21). Due to the involvement of the alveoli in COVID-19 pneumonia, it is vital to deliver oxygen at the right concentration to maintain oxygen saturation and avoid decreased partial pressure of oxygen.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious respiratory disease. Many treatments have been used to prevent and treat this disease. However, simple solutions, such as mild exercise (22), hand washing, and social distance (23) are effective in preventing and even treating COVID-19. Yet, there is no known cure other than vaccines (as prophylactic agents). Despite all the clinical experiences, protocols presented, and extensive research, COVID-19 patient management is still an extremely challenging issue (particularly critically ill patients). Therefore, along with completing information about the pathophysiology of this disease, therapeutic interventions for critically ill patients might be the standard care and proper and primary diagnosis and treatment (24). Health care providers, particularly anesthesia and ICU physicians experience mental stress and anxiety. This mental stress could be worsened with the fear of disease transmission and contamination (25).

2. Methods

The literature search to identify articles on intubation statistics and COVID- 19 was conducted using the PubMed, Embase, and Scopus databases on April 1, 2021. The publication time was limited to 2020 onward. A total of 4,680 papers were identified by the initial search (Figure 1). Three independent reviewers assessed the abstracts and full texts. The inclusion criterion was studies presenting the percentage of COVID-19 patients (not all patients) who required endotracheal intubation. Reports regarding intubation in COVID19 patients presenting the rate of intubation were included in this review. The study was limited to the papers written in the English language. Exclusion criteria were non-English papers, papers on non-human subjects, case reports, and case series with less than 10 patients. The main question of this review was how many patients infected with COVID-19 were intubated? And what are the associated factors?

This study was approved by the Internal Ethical Committee of Critical Care, Imam Khomeini Hospital (IR.TUMS.VCR.REC.1399.389).

Figure 1.

The PRISMA 2009 flow diagram

3. Results

Overall, 24 studies regarding the intubation rate in COVID-19 patients were included in the final analysis (Tables 1 and 2). Most of the patients had been intubated in the ICU. Studies had been conducted in the USA, Spain, Italy, China, South Korea, Brazil, and Iran.

Table 1.

Statistics of the Intubation of COVID-19 Patients

References	Sex	Age	Ward	Extubation Rate (%)	Intubation Rate (%)	Cause (s) of Intubation	Country
(26)	210 Male patients, 128 Female patients	39 (IQR 31- 45)	ED	_	8 % (28 out of 338)	Respiratory failure	USA
(27)	78 patients (Not specified)	58.4 ± 13.7	ICU	_	12.82 % (10 out of 78)	Respiratory failure	Iran
(28)	60 % Male, 40 % Female	59	ED	_	13 %	Long-term Hypoxia	USA
(29)	Mostly Male	50 - 81	Oncology	_	5 %	Hypoxia and Lung injury caused by decreased oxygen	USA
(30)	Mostly Male	47 -70	Infectious disease	_	26.7 %	Hypoxia	USA
(31)	52 % (53/102) Male, 48% (49/102) Female	68 (IQR 61-75)	ICU	_	57% women (59 out of 102)	Hypoxic respiratory failure	USA
(32)	78 % (83/108) Male, 22 % (25/183) Female	64 (IQR 57-70)	ICU	12/822 (1.4%)	20 % (163 out of 822)	_	Italy
(33)	137 (71%) Male patients	60 ± 13.8	_	_	62.7 %	_	USA
(34)	90 (53%) Male patients	57 ± 11	ICU	_	38.29 %	_	USA
(35)	53(33%) Male patients	62 ± 14.3	ICU	_	_	ARDS	USA
(36)	35 (67%) Male patients, 17 (33%) Female patients	59·7 ± 13·3	ICU	_	42 % (22 out of 52)	ARDS	China
(5)	1304 Male patients, 287 Female patients	63 (IQR 56 – 70)	ICU	_	88 % (1150 out of 1591)	Hypoxia and ARDS	Italy
(37)	49% Male: PE group, 45% Male: non-PE group	62 ± 16 PE group, 59 ± 15 non-PE group	ICU	_	65 % in Pulmonary Embolism patients, 67 % in the non- Pulmonary Embolism patients	Hypoxia and PE	(37)
(38)	No data available	No data available	ICU	44.5% (842 out of 1890)	16.4 % (1890 out of 11493)	-	Spain
(13)	9 Male patients, 7 Female patients	58 (IQR,47 – 68)	ICU	-	56.25 % (9 out of 16)	Respiratory failure	China
(39)	No data available	No data available	ICU	-	41.20 % (82 out of 199)	Acute respiratory failure	Spain
(40)	28 Male patients, 19 Female patients	70 years (IQR, 63 - 77)	ICU	-	48.9 % (23 out of 47) (early intubation^a), 34 % (16 out of 47) (late intubation^b)	ARDS	South Korea
(41)	88 Male patients, 50 Female patients	55 cases ≤ 60 years, 83 > 60 years	ED, ICU, and other wards	56.5 % (78 out of 138)	24.8 % (138 out of 486)	Decreased oxygen saturation, Shortness of breath	USA
(9)	92 Male patients, 38 Female patients	64.5 years (IQR, 51.7 - 73.6	_	33.1 % (43 out of 130)	33.1 % (130 out of 393)	Dyspnea	USA
(42)	25 Male patients, 5 Female patients	65.5 years (IQR, 57 - 71)	_	20 % (6 out of 30)	23.25 % (30 out of 129)	Hypoxemia	USA
(43)	No data available	65 years (IQR, 53 - 77)	Various wards	_	10.6 % (467 out of 4389)	Decreased Oxygen saturation, Hypoxia	USA
(44)	37 Male patients, 45 Female patients	No data available	_	_	33.75 % (27 out of 82)	Hypoxia	USA
(45)	112 Male patients, 54 Female patients	58.1 ± 14.1	ED	_	58 % prone positioning (33 out of 57), 49 % No Prone (53 out of 109)	Hypoxia, tachypnea	Brazil
(46)	129 Male patients, 93 Female patients	69.5 (IQR, 62 - 78)	Various wards	_	41 % Intubation First (91 out of 222), 20 % NIV to intubation (44 out of 222)	ARDS, Hypoxia, Altered Mental Status	USA

Abbreviations: ARDS, acute respiratory distress syndrome; ED, emergency department.

^a Early intubation: intubation as soon as ARDS diagnosis.

^b Late intubation: not initially intubated, but subsequently required intubation during follow-up.

Table 2.

Summary of the Studies and Grade of Recommendation

First Authors	Year	Study Design	Grade Of Recommendation	Reference
Toussie D	2020	Retrospective study	B	(26)
Ansarin K	2020	Randomized clinical trial	A	(27)
Caputo ND	2020	observational cohort study	B	(28)
Miyashita H	2020	n/a	-	(29)
Sinha P	2020	Randomized clinical trial	A	(30)
Luo J	2020	Retrospective study	B	(31)
Bartoletti M	2020	Prospective study	B	(32)
Rojas-Marte G	2020	Retrospective study	B	(33)
Pereira MR	2020	Initial cohort study	B	(34)
Chao TN	2020	Prospective observational cohort study	B	(35)
Sommer P	2020	n/a	-	(36)
Grasselli G	2020	Retrospective case series	C	(5)
Poyiadji N	2020	Retrospective analysis	B	(37)
Martin-Villares C	2020	Prospective observational study	C	(38)
Lu X, Zhang M	2020	Prospective observational study	C	(13)
Ferrando C	2020	Adjusted cohort study	B	(39)
Lee YH	2020	Retrospective Study	B	(40)
Hur K	2020	Retrospective observational study	C	(41)
Goyal P	2020	retrospective case series	C	(9)
Mughal MS	2020	Retrospective study	B	(42)
Nadkarni GN	2020	Retrospective analysis	B	(43)
Barlass U	2020	Cohort study	B	(44)
Padrão EM	2020	Retrospective cohort study	B	(45)
Daniel P	2020	Retrospective study	B	(46)

Various statistics of intubation rate in COVID-19 patients are reported ranging from 5 - 88 %. This difference in statistics can be due to differences in sample size, study environment (wards), and intubation criteria (28, 31). Rapid sequence induction (RSI) or modified RSI was mostly used for intubation (47). Propofol was used mostly in all cases and often in combination with other sedative agents, like rocuronium, sufentanil, and midazolam. Studies have shown that factors affecting COVID-19 severity (such as underlying disease, the age of more than 50 years, smoking, body mass index, and comorbidity condition) could exacerbate a patient's condition and accelerate the necessity for endotracheal intubation (29, 31). The most important reasons that require endotracheal intubation are hypoxia, respiratory distress, and loss of consciousness (13, 26, 27). Xu et al. suggested that the most prominent reason for intubation in critically ill patients is the lack of respiratory sufficiency. However, in some cases, airway obstruction (or aspiration) and cardiac insufficiency are the intubation causes (48).

Some studies have revealed that due to the limited capacity of ICUs during the COVID-19 pandemic (49), tracheostomy seems to be a suitable solution for patients for weaning from the mechanical ventilation (50), decreasing the respiratory effort in patients with limited pulmonary reserves, reducing the dead space, and enabling the suctioning of accumulated mucous (38).

Despite the rarity of available studies regarding extubation in COVID-19 patients, it has been revealed that the extubation rate ranges from 1.4 % to 44.5% (32, 38).

4. Discussion and Conclusions

SARS-CoV-2 was the coronavirus responsible for the COVID-19 pandemic in 2020. COVID-19 may induce severe respiratory distress. Acute respiratory distress in COVID-19 patients could require endotracheal intubation and mechanical ventilation. Proper intubation and management of patients with COVID-19 are integral parts of critically ill patient's management. In confirmation, a study stated that of the patients who died, only ~ 25% received invasive mechanical ventilation (intubated) or extracorporeal membrane oxygenation (ECMO) (51). It seems that the lack of a ventilator or delayed intubation may be one of the causes of deterioration disease in COVID-19 patients.

It has been suggested that (52), less than a third of patients with COVID-19, may benefit from high-flow nasal cannula therapy, noninvasive ventilation, and awake prone position. Patients who have extubated can also benefit from this treatment strategy. The use of awake prone positioning as a supplement therapy to high-flow nasal oxygen therapy did not reduce the risk of intubation and mechanical ventilation (53). However, it could cause delayed in intubation (39). It seems that there are no significant differences in mortality rate between the early intubation group and never intubated patients (40).

According to the necessity of intubation, specialists suggested the use of esophageal manometry (as a surrogate of pleural pressure) and considering intubation when pressure swings exceed 15 cm H2O indicating the risk of self-inflicted lung injury (54). Based on experience-based recommendations, once the patient's noninvasive ventilation failed, elective intubation should be preferred to minimize clinical risks, such as contamination of medical staff (55). Adequate application of personal protective equipment can reduce the risk of nosocomial infections for proceduralists (56). It is recommended that healthcare providers be committed to hand hygiene, airborne precautions, and donning personal protective equipment (57), particularly in airway management circumstances. It is worth noting that in cases where patients need an emergency tracheostomy, utilizing personal protection equipment, such as fit-tested N95 respirator, face shields, and double gloving, can reduce the risk of contamination (58).

Several factors are associated with intubation in COVID-19 patients. Elderly patients, male patients, and those with background diseases, particularly hypertension and diabetes, are more at risk of intubation (1, 15, 35, 56). Also, chest CT scan and respiratory rate are important prognostic factors in determining the severity of the disease and overall prognosis (59). Increased levels of ferritin, d-dimer, and lipase in common with hypoxia are correlated with intubation and ICU admission (42, 44). It was found that anticoagulation use is associated with lower intubation (43). Pulmonary embolism and cardiac tamponade are two complications of COVID-19 patients at the time of ICU admission. If proper emergency management initiates, the patient's life might be saved (60). ROX index is a noninvasive and outstanding predictor for the necessity of intubation in COVID-19 patients (61). The ROX index is the ratio of oxygen saturation that is measured by pulse oximetry. The fraction of inspired oxygen to respiratory rate is a feasible tool as a predictor of the need to intubate in patients who received high flow nasal cannula oxygen therapy (62).

In terms of difficult airway management, the upper airway nerve block method may be proper for tracheal stenosis patients who are rigid bronchoscopy candidates (63). Also, it is suggested that video laryngoscopy in comparison to direct laryngoscopy can provide better visualization for intubation of the trachea in congenital heart disease. However, it needs time and a well-trained expert (64). In children with tongue trauma, a flexible laryngeal mask airway is more appropriate in comparison to the endotracheal tube because it reduces extubation time, recovery period, and hemodynamic changes to the airway control (65).

Although appropriate positioning is an essential part of successful intubation, awake-prone positioning may not be correlated with intubation rates (45). Furthermore, there was no significant change in terms of PaO2 before prone positioning and after resupination (66).

It seems that noninvasive ventilation (NIV) may have survival benefits so that patients who received NIV have lower mortality than patients who did not receive NIV and were intubated (46). Solaimanzadeh suggested that some calcium channel blocker agents, like nifedipine and amlodipine, may remarkably meliorate mortality and reduce the risk of intubation and the need for mechanical ventilation in elder COVID-19 patients (67).

The intubation rate has been reported to be 5 to 88 %. In a review study by da Silva et al., intubation need vary from 42% to 47% (68). Besides, Cardona et al. reported that the intubation rate was 28% among hypoxic COVID-19 patients (69). This discrepancy in statistics may be due to the variety of study populations, study environments, or intubation criteria. However, there are a few pieces of evidence regarding extubation; therefore, more investigations are required to determine intubation outcomes and extubation. Obesity and old age are the only risk factors of delayed or difficult extubation (41).

In terms of mortality of the patients undergoing subsequent intubation, it was reported to be vary from 15.2% (41), 23.1% (27), 24.5% (4), to 36.0% (70). Hernandez-Romieu et al. (53) found no association between time to intubation and mortality of infected patients. However, regarding non-COVID-19 ICU mortality, mortality during intubation-related and the overall ICU mortality rate in intubated patients were 1% and 30%, respectively (71).

Due to the lack of definitive treatment for COVID-19, and the research-based empirical treatments, it seems that a comprehensive intubation algorithm in COVID-19 patients is extensively required (71).

We reviewed the intubation rates based on previous studies. These statistics are preliminary and more studies are needed to examine factors affecting the intubation of patients and the correlation between them.

4.1. Limitations

This narrative review design of the study limited our preference for the intubation rate of COVID-19 patients. Therefore, selection bias is possible. Also, causality relationships between disease severity and intubation and extubation might be neglected. This review was limited to English language papers possibly leading to missing some valuable manuscripts in other languages.

4.2. Recommendations

According to studies and reported experiences, we hereby provide some experienced and evidence-based recommendations that can improve the quality of care: 1) Utilizing personal protective equipment to prevent transmission; 2) It is better than the most experienced specialist intubates patients; 3) Noninvasive ventilation may correct oxygenation and is associated with survival benefits. It can be considered for patients who tolerate it; Rapid sequence induction in combination with video laryngoscopy enabled swift intubation (36); Necessary equipment should be available prior to intubation procedure (monitoring, intravenous access, resuscitator medications, ventilator, and suction) (53); and considering calcium channel blocker agents (particularly nifedipine and amlodipine) for hypertensive patients (if applicable) (67).

Acknowledgements

Footnotes

Authors' Contribution: Study concept and design: M. M., and H.A. V.; Analysis and interpretation of data: H. A. V., Drafting of the manuscript: M. M. H.A.V; Critical revision of the manuscript for important intellectual content: M. M., H. A.V., and A. R.K.P.K; Statistical analysis: H. A.V.
Conflict of Interests: The authors have no conflict of interests to declare.
Funding/Support: This study did not receive any funding.

References

1.
Mohammadi M, Varpaei HA, Amini M. Intubation prognosis in COVID-19 patients and associated factors: a cross-sectional study. Research Square. 2020. https://doi.org/10.21203/rs.3.rs-115894/v1.
2.
Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020;18(7):1752-5. [PubMed ID: 32267998]. [PubMed Central ID: PMC7262152]. https://doi.org/10.1111/jth.14828.
3.
Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hernandez M, Gea A, Arruti E, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46(12):2200-11. [PubMed ID: 32728965]. [PubMed Central ID: PMC7387884]. https://doi.org/10.1007/s00134-020-06192-2.
4.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052-9. [PubMed ID: 32320003]. [PubMed Central ID: PMC7177629]. https://doi.org/10.1001/jama.2020.6775.
5.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region, Italy. JAMA. 2020;323(16):1574-81. [PubMed ID: 32250385]. [PubMed Central ID: PMC7136855]. https://doi.org/10.1001/jama.2020.5394.
6.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [PubMed ID: 31986264]. [PubMed Central ID: PMC7159299]. https://doi.org/10.1016/S0140-6736(20)30183-5.
7.
Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience. Anesthesiology. 2020;132(6):1317-32. [PubMed ID: 32195705]. [PubMed Central ID: PMC7155908]. https://doi.org/10.1097/ALN.0000000000003296.
8.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. [PubMed ID: 32105632]. [PubMed Central ID: PMC7102538]. https://doi.org/10.1016/S2213-2600(20)30079-5.
9.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372-4. [PubMed ID: 32302078]. [PubMed Central ID: PMC7182018]. https://doi.org/10.1056/NEJMc2010419.
10.
Wali A, Rizzo V, Bille A, Routledge T, Chambers AJ. Pneumomediastinum following intubation in COVID-19 patients: a case series. Anaesthesia. 2020;75(8):1076-81. [PubMed ID: 32375200]. [PubMed Central ID: PMC7267505]. https://doi.org/10.1111/anae.15113.
11.
Gulart AA, Silva I. Early prone position for COVID-19 patients with severe hypoxia: reduces the mortality but increases the intubation risk? Intensive Care Med. 2020;46(11):2124-5. [PubMed ID: 32816097]. [PubMed Central ID: PMC7438396]. https://doi.org/10.1007/s00134-020-06213-0.
12.
Kangelaris KN, Ware LB, Wang CY, Janz DR, Zhuo H, Matthay MA, et al. Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med. 2016;44(1):120-9. [PubMed ID: 26474112]. [PubMed Central ID: PMC4774861]. https://doi.org/10.1097/CCM.0000000000001359.
13.
Lu X, Zhang M, Qian A, Tang L, Xu S. Lung ultrasound score in establishing the timing of intubation in COVID-19 interstitial pneumonia: A preliminary retrospective observational study. PLoS One. 2020;15(9). e0238679. [PubMed ID: 32881950]. [PubMed Central ID: PMC7470341]. https://doi.org/10.1371/journal.pone.0238679.
14.
Brewster DJ, Chrimes N, Do TB, Fraser K, Groombridge CJ, Higgs A, et al. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. Med J Aust. 2020;212(10):472-81. [PubMed ID: 32356900]. [PubMed Central ID: PMC7267410]. https://doi.org/10.5694/mja2.50598.
15.
Kafan S, Tadbir Vajargah K, Sheikhvatan M, Tabrizi G, Salimzadeh A, Montazeri M, et al. Predicting Risk Score for Mechanical Ventilation in Hospitalized Adult Patients Suffering from COVID-19. Anesthesiology and Pain Medicine. 2021;11(2). https://doi.org/10.5812/aapm.112424.
16.
Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med. 2020;202(3):356-60. [PubMed ID: 32539537]. [PubMed Central ID: PMC7397783]. https://doi.org/10.1164/rccm.202006-2157CP.
17.
Haryalchi K, Heidarzadeh A, Abedinzade M, Olangian-Tehrani S, Ghazanfar Tehran S. The Importance of Happy Hypoxemia in COVID-19. Anesth Pain Med. 2021;11(1). e111872. [PubMed ID: 34221943]. [PubMed Central ID: PMC8239260]. https://doi.org/10.5812/aapm.111872.
18.
Ling L, Joynt GM, Lipman J, Constantin JM, Joannes-Boyau O. COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics. Anaesth Crit Care Pain Med. 2020;39(2):163-6. [PubMed ID: 32088344]. [PubMed Central ID: PMC7119083]. https://doi.org/10.1016/j.accpm.2020.02.002.
19.
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4). e35797. [PubMed ID: 22563403]. [PubMed Central ID: PMC3338532]. https://doi.org/10.1371/journal.pone.0035797.
20.
Fowler RA, Guest CB, Lapinsky SE, Sibbald WJ, Louie M, Tang P, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med. 2004;169(11):1198-202. [PubMed ID: 14990393]. https://doi.org/10.1164/rccm.200305-715OC.
21.
Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0). E005. [PubMed ID: 32026671]. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0005.
22.
Mohammadi M, Hadian MR, Varpaei HA. Exercise in COVID-19: Intensity and Timing. Asian J Sports Med. 2021;In Press(In Press). https://doi.org/10.5812/asjsm.113266.
23.
Pergolizzi JJ, Magnusson P, LeQuang JA, Breve F, Paladini A, Rekatsina M, et al. The Current Clinically Relevant Findings on COVID-19 Pandemic. Anesth Pain Med. 2020;10(2). e103819. [PubMed ID: 32754437]. [PubMed Central ID: PMC7352949]. https://doi.org/10.5812/aapm.103819.
24.
Mahmoodpoor A, Shadvar K, Ghamari AA, Mohammadzadeh Lameh M, Asghari Ardebili R, Hamidi M, et al. Management of critically Ill patients with COVID-19: What we learned and what we do. Anesth Pain Med. 2020;10(3). https://doi.org/10.5812/aapm.104900.
25.
Ali H, Ismail AA, Abdalwahab A. Mental stress in anesthesia and intensive care physicians during COVID-19 outbreak. Anesth Pain Med. 2020;10(5). https://doi.org/10.5812/aapm.106623.
26.
Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Manna S, Maron SZ, et al. Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology. 2020;297(1):E197-206. [PubMed ID: 32407255]. [PubMed Central ID: PMC7507999]. https://doi.org/10.1148/radiol.2020201754.
27.
Ansarin K, Tolouian R, Ardalan M, Taghizadieh A, Varshochi M, Teimouri S, et al. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial. Bioimpacts. 2020;10(4):209-15. [PubMed ID: 32983936]. [PubMed Central ID: PMC7502909]. https://doi.org/10.34172/bi.2020.27.
28.
Caputo ND, Strayer RJ, Levitan R. Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience During the COVID-19 Pandemic. Acad Emerg Med. 2020;27(5):375-8. [PubMed ID: 32320506]. [PubMed Central ID: PMC7264594]. https://doi.org/10.1111/acem.13994.
29.
Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020;31(8):1088-9. [PubMed ID: 32330541]. [PubMed Central ID: PMC7172785]. https://doi.org/10.1016/j.annonc.2020.04.006.
30.
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, et al. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020;99:28-33. [PubMed ID: 32721528]. [PubMed Central ID: PMC7591937]. https://doi.org/10.1016/j.ijid.2020.07.023.
31.
Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):1386-96. [PubMed ID: 32561401]. [PubMed Central ID: PMC7297689]. https://doi.org/10.1016/j.annonc.2020.06.007.
32.
Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. 2020. [PubMed ID: 32719848]. [PubMed Central ID: PMC7454393]. https://doi.org/10.1093/cid/ciaa1065.
33.
Rojas-Marte G, Khalid M, Mukhtar O, Hashmi AT, Waheed MA, Ehrlich S, et al. Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study. QJM. 2020;113(8):546-50. [PubMed ID: 32569363]. [PubMed Central ID: PMC7337835]. https://doi.org/10.1093/qjmed/hcaa206.
34.
Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20(7):1800-8. [PubMed ID: 32330343]. [PubMed Central ID: PMC7264777]. https://doi.org/10.1111/ajt.15941.
35.
Chao TN, Harbison SP, Braslow BM, Hutchinson CT, Rajasekaran K, Go BC, et al. Outcomes after tracheostomy in COVID-19 patients. Ann Surg. 2020;272(3):e181-6. [PubMed ID: 32541213]. [PubMed Central ID: PMC7467054]. https://doi.org/10.1097/SLA.0000000000004166.
36.
Sommer P, Lukovic E, Fagley E, Long DR, Sobol JB, Heller K, et al. Initial clinical impressions of the critical care of COVID-19 patients in seattle, New York City, and Chicago. Anesth Analg. 2020;131(1):55-60. [PubMed ID: 32221172]. [PubMed Central ID: PMC7172559]. https://doi.org/10.1213/ANE.0000000000004830.
37.
Poyiadji N, Cormier P, Patel PY, Hadied MO, Bhargava P, Khanna K, et al. Acute pulmonary embolism and COVID-19. Radiology. 2020;297(3):E335-8. [PubMed ID: 32407256]. [PubMed Central ID: PMC7706099]. https://doi.org/10.1148/radiol.2020201955.
38.
Martin-Villares C, Perez Molina-Ramirez C, Bartolome-Benito M, Bernal-Sprekelsen M, Covid Orl Esp Collaborative Group. Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain. Eur Arch Otorhinolaryngol. 2021;278(5):1605-12. [PubMed ID: 32749607]. [PubMed Central ID: PMC7399582]. https://doi.org/10.1007/s00405-020-06220-3.
39.
Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Adalia R, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study. Crit Care. 2020;24(1):597. [PubMed ID: 33023669]. [PubMed Central ID: PMC7537953]. https://doi.org/10.1186/s13054-020-03314-6.
40.
Lee YH, Choi KJ, Choi SH, Lee SY, Kim KC, Kim EJ, et al. Clinical significance of timing of intubation in critically Ill patients with COVID-19: A multi-center retrospective study. J Clin Med. 2020;9(9). [PubMed ID: 32887462]. [PubMed Central ID: PMC7564702]. https://doi.org/10.3390/jcm9092847.
41.
Hur K, Price CPE, Gray EL, Gulati RK, Maksimoski M, Racette SD, et al. Factors associated with intubation and prolonged intubation in hospitalized patients with COVID-19. Otolaryngol Head Neck Surg. 2020;163(1):170-8. [PubMed ID: 32423368]. [PubMed Central ID: PMC7240317]. https://doi.org/10.1177/0194599820929640.
42.
Mughal MS, Kaur IP, Jaffery AR, Dalmacion DL, Wang C, Koyoda S, et al. COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity. Respir Med. 2020;172:106130. [PubMed ID: 32896798]. [PubMed Central ID: PMC7455149]. https://doi.org/10.1016/j.rmed.2020.106130.
43.
Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno PR, Pujadas E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(16):1815-26. [PubMed ID: 32860872]. [PubMed Central ID: PMC7449655]. https://doi.org/10.1016/j.jacc.2020.08.041.
44.
Barlass U, Wiliams B, Dhana K, Adnan D, Khan SR, Mahdavinia M, et al. Marked elevation of lipase in COVID-19 disease: A cohort study. Clin Transl Gastroenterol. 2020;11(7). e00215. [PubMed ID: 32764201]. [PubMed Central ID: PMC7386395]. https://doi.org/10.14309/ctg.0000000000000215.
45.
Padrao EMH, Valente FS, Besen B, Rahhal H, Mesquita PS, de Alencar JCG, et al. Awake prone positioning in COVID-19 hypoxemic respiratory failure: Exploratory findings in a single-center retrospective cohort study. Acad Emerg Med. 2020;27(12):1249-59. [PubMed ID: 33107664]. https://doi.org/10.1111/acem.14160.
46.
Daniel P, Mecklenburg M, Massiah C, Joseph MA, Wilson C, Parmar P, et al. Non-invasive positive pressure ventilation versus endotracheal intubation in treatment of COVID-19 patients requiring ventilatory support. Am J Emerg Med. 2021;43:103-8. [PubMed ID: 33550100]. [PubMed Central ID: PMC7844386]. https://doi.org/10.1016/j.ajem.2021.01.068.
47.
Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Br J Anaesth. 2020;125(1):e28-37. [PubMed ID: 32312571]. [PubMed Central ID: PMC7151238]. https://doi.org/10.1016/j.bja.2020.03.026.
48.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. [PubMed ID: 32085846]. [PubMed Central ID: PMC7164771]. https://doi.org/10.1016/S2213-2600(20)30076-X.
49.
Antommaria AHM, Gibb TS, McGuire AL, Wolpe PR, Wynia MK, Applewhite MK, et al. Ventilator triage policies during the COVID-19 pandemic at U.S. Hospitals associated with members of the association of bioethics program directors. Ann Intern Med. 2020;173(3):188-94. [PubMed ID: 32330224]. [PubMed Central ID: PMC7207244]. https://doi.org/10.7326/M20-1738.
50.
Hamilton NJI, Jacob T, Schilder AGM, Arora A, George MM, Green F, et al. COVID Trach; the outcomes of mechanically ventilated COVID-19 patients undergoing tracheostomy in the UK. medRxi. 2020. https://doi.org/10.1101/2020.05.22.20104679.
51.
Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020;46(5):837-40. [PubMed ID: 32123994]. [PubMed Central ID: PMC7080165]. https://doi.org/10.1007/s00134-020-05979-7.
52.
Raoof S, Nava S, Carpati C, Hill NS. High-flow, noninvasive ventilation and awake (nonintubation) proning in patients with coronavirus disease 2019 with respiratory failure. Chest. 2020;158(5):1992-2002. [PubMed ID: 32681847]. [PubMed Central ID: PMC7362846]. https://doi.org/10.1016/j.chest.2020.07.013.
53.
Hernandez-Romieu AC, Adelman MW, Hockstein MA, Robichaux CJ, Edwards JA, Fazio JC, et al. Timing of Intubation and Mortality Among Critically Ill Coronavirus Disease 2019 Patients: A Single-Center Cohort Study. Crit Care Med. 2020;48(11):e1045-53. [PubMed ID: 32804790]. [PubMed Central ID: PMC7448713]. https://doi.org/10.1097/CCM.0000000000004600.
54.
Apigo M, Schechtman J, Dhliwayo N, Al Tameemi M, Gazmuri RJ. Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia. Crit Care. 2020;24(1):477. [PubMed ID: 32736637]. [PubMed Central ID: PMC7393620]. https://doi.org/10.1186/s13054-020-03176-y.
55.
Sorbello M, Morello G, Pintaudi S, Cataldo R. COVID-19: Intubation Kit, Intubation Team, or Intubation Spots? Anesth Analg. 2020;131(2):e128-30. [PubMed ID: 32404591]. https://doi.org/10.1213/ANE.0000000000004970.
56.
Zheng H, Li S, Sun R, Yang H, Chi X, Chen M, et al. Clinical experience with emergency endotracheal intubation in COVID-19 patients in the intensive care units: a single-centered, retrospective, descriptive study. Am J Transl Res. 2020;12(10):6655-64. [PubMed ID: 33194062]. [PubMed Central ID: PMC7653591].
57.
Rahmani F, Mahmoodpoor A, Salmasi S, Ebrahimi Bakhtavar H. Safety of Healthcare Workers During the Airway Management in Adult and Pediatric Patients with COVID-19. Anesth Pain Med. 2021;11(2). e112508. https://doi.org/10.5812/aapm.112508.
58.
Hassani V, Amniati S, Ahmadi A, Mohseni M, Sehat-Kashani S, Nikoubakht N, et al. Emergency Tracheostomy in Two Airway Trauma Patients Suspected of COVID-19: A Case Report. Anesth Pain Med. 2020;10(4). e104648. https://doi.org/10.5812/aapm.104648.
59.
Rahimzadeh P, Faiz HR, Farahmandrad R, Hassanlouei B, Habibi A, Hedayati Emami S, et al. Clinical Features and Prognosis of Invasive Ventilation in Hospitalized Patients with COVID-19: A Retrospective Study. Anesth Pain Med. 2020;10(6). e108773. https://doi.org/10.5812/aapm.108773.
60.
Mohammed Sheata I, Smith SR, Kamel H, Varrassi G, Imani F, Dayani A, et al. Pulmonary Embolism and Cardiac Tamponade in Critical Care Patients with COVID-19; Telemedicine’s Role in Developing Countries: Case Reports and Literature Review. Anesth Pain Med. 2021;11(2). e113752. https://doi.org/10.5812/aapm.113752.
61.
Patel M, Chowdhury J, Mills N, Marron R, Gangemi A, Dorey-Stein Z, et al. ROX index predicts intubation in patients with COVID-19 pneumonia and moderate to severe hypoxemic respiratory failure receiving high flow nasal therapy. medRxiv. 2020. https://doi.org/10.1101/2020.06.30.20143867.
62.
Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernandez G, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019;199(11):1368-76. [PubMed ID: 30576221]. https://doi.org/10.1164/rccm.201803-0589OC.
63.
Naguib TM, Ahmed SA. Evaluation of Flexible Laryngeal Mask Airway((R)) in Tongue Trauma Repair: A Randomized Trial. Anesth Pain Med. 2019;9(4). e92929. [PubMed ID: 31750096]. [PubMed Central ID: PMC6820298]. https://doi.org/10.5812/aapm.92929.
64.
Amri P, Nikbakhsh N, Modaress SR, Nosrati R. Upper Airway Nerve Block for Rigid Bronchoscopy in the Patients with Tracheal Stenosis: A Case Serie. Anesth Pain Med. 2020;10(4). e99796. [PubMed ID: 33134141]. [PubMed Central ID: PMC7539043]. https://doi.org/10.5812/aapm.99796.
65.
Javaherforooshzadeh F, Gharacheh L. The Comparison of Direct Laryngoscopy and Video Laryngoscopy in Pediatric Airways Management for Congenital Heart Surgery: A Randomized Clinical Trial. Anesth Pain Med. 2020;10(3). e99827. https://doi.org/10.5812/aapm.99827.
66.
Elharrar X, Trigui Y, Dols AM, Touchon F, Martinez S, Prud'homme E, et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA. 2020;323(22):2336-8. [PubMed ID: 32412581]. [PubMed Central ID: PMC7229532]. https://doi.org/10.1001/jama.2020.8255.
67.
Solaimanzadeh I. Nifedipine and amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized for COVID-19. Cureus. 2020;12(5). e8069. [PubMed ID: 32411566]. [PubMed Central ID: PMC7219014]. https://doi.org/10.7759/cureus.8069.
68.
Gomes Neto M, Moura Filho OFD, Lima Filho WC, Carvalho VO, Gomes VA, Almeida RDS, et al. Evidence-based Physiotherapy and Functionality in Adult and Pediatric patients with COVID-19. J Hum Growth Dev. 2020;30(1):148-55. https://doi.org/10.7322/jhgd.v30.10086.
69.
Cardona S, Downing J, Alfalasi R, Bzhilyanskaya V, Milzman D, Rehan M, et al. Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: A meta-analysis. Am J Emerg Med. 2021;43:88-96. [PubMed ID: 33550104]. [PubMed Central ID: PMC7839795]. https://doi.org/10.1016/j.ajem.2021.01.058.
70.
Orser BA. Recommendations for Endotracheal Intubation of COVID-19 Patients. Anesth Analg. 2020;130(5):1109-10. [PubMed ID: 32209810]. [PubMed Central ID: PMC7172572]. https://doi.org/10.1213/ANE.0000000000004803.
71.
Hussain Khan Z, Sasaa MA, Mohammadi M, Alipour A, Hajipour A. Mortality Related to Intubation in Adult General ICUs: A Systematic Review and Meta-Analysis. Arch Neurosci. 2020;7(3). https://doi.org/10.5812/ans.89993.

comments